Rarecells Diagnostics

Rarecells Diagnostics Rarecells Diagnostics develops and commercializes the ISET technology to isolate Circulating Tumor Cells for early cancer diagnosis and medical research.

Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique Hôpitaux de Paris and INSERM protecting the Rarecells® Device and its consumables, as well as the analyses performed on cells isolated using the Rarecells® System. Rarecells® Diagnostics is a science-driven company. We are scientists working for scientists and patients. We care about bringing benefits to the patients.The team delivers customer satisfaction by manufacturing high quality products and providing high-level scientific assistance

Diagnosis of circulating cancer cells is critical in predictive oncology
09/02/2015

Diagnosis of circulating cancer cells is critical in predictive oncology

A key issue with cancers that continue to have lower patient survivability rates, such as lung cancer, cervical cancer and colorectal cancer, is that they are often not diagnosed until later stages. Many times this means that cancer is not diagnosed until after it has metastasized, or spread to othe…

Isolation of circulating tumor cells of all types without loss is a technical challenge
06/02/2015

Isolation of circulating tumor cells of all types without loss is a technical challenge

Circulating Tumor Cells (CTCs) are cells from a primary tumor that shed into a patient’s bloodstream. These cells can often be detected years before a cancer reaches metastasis, the later stages of cancer in which it becomes more difficult to treat successfully. Detection of these cells in a patient…

Did you know that circulating cancer cells are present in the blood years before metastases?
06/02/2015

Did you know that circulating cancer cells are present in the blood years before metastases?

It is widely accepted that the earlier cancer is diagnosed, the more likely a patient is to survive. The problem with the deadliest forms of cancer, such as lung, colorectal or cervical cancer among others, is that patients often remain asymptomatic until later stages. If these patients aren’t seein…

Combining preventive CT scans and screening of circulating cancer cells can maximize the potential of new Medicare initi...
05/02/2015

Combining preventive CT scans and screening of circulating cancer cells can maximize the potential of new Medicare initiative

As the U.S. Centers for Medicare & Medicaid Services begins to fund lung-cancer screening using low-dose helical computerized tomography...

Here's a great interview with Dr. Paul Hofman regarding his paper on Sentinel Circulating Tumor Cells and early lung can...
05/02/2015

Here's a great interview with Dr. Paul Hofman regarding his paper on Sentinel Circulating Tumor Cells and early lung cancer diagnosis in COPD patients

Lead author Paul Hofman, MD, discusses the patient population and the 5 patients who were diagnosed early with lung cancer and treated successfully

Our own Patrizia Paterlini-Brechot PhD. speaking with Christophe Hondelatte of BFMTV France about early detection of Cir...
08/12/2014

Our own Patrizia Paterlini-Brechot PhD. speaking with Christophe Hondelatte of BFMTV France about early detection of Circulating Cancer Cells by ISET.

Presentation by the Pr. Patrizia Paterlini-Bréchot of the ISET® test by Rarecells® for early diagnosis of lung cancer.

We're thrilled that the latest paper validating the identification of circulating tumor cells for early diagnosis on lun...
18/11/2014

We're thrilled that the latest paper validating the identification of circulating tumor cells for early diagnosis on lung cancer in patients with COPD is in the Top 10 at PLOS One!

The research study on the use of ISET by Rarecells to diagnose and treat lung cancer at the first signs of tumor growth is in the Top 10 of most viewed research papers at the Public Library of Science (PLOS) ONE open-access journal.

Check out all the latest news on Rarecells and ISET!
18/11/2014

Check out all the latest news on Rarecells and ISET!

ScienceDaily Lung Disease News Lung Cancer News Today Medical Lab Observer Journal Clinical Lab Products Respiratory Therapy BioSpace BioScienceTechnology.com NewsMaxHealth Herald

As Medicare announces funding for CT scan screening - keep in mind that Circulating Tumor Cells have the potential to he...
18/11/2014

As Medicare announces funding for CT scan screening - keep in mind that Circulating Tumor Cells have the potential to help diagnose those patients at greatest risk.

On Nov. 10,2014, the U.S. Centers for Medicare & Medicaid Services (CMS) announced that it will fund low-dose helical computerized tomography (CT) screening for those at high risk for lung cancer, specifically those aged 55-74 who are defined at “heavy smokers” (1 pack per day for the last 30 years…

From Science Daily! Exciting coverage of the new study with a focus on diagnosis of lung cancer before it is detected by...
04/11/2014

From Science Daily! Exciting coverage of the new study with a focus on diagnosis of lung cancer before it is detected by imaging. http://goo.gl/kt0Eox

It is possible to detect, in patients at risk of developing lung cancer, early signs of the disease in the form of circulating cancer cells, several months, and in some cases several years, before the cancer becomes detectable by CT scanning, researchers report. This warning could play a key role in…

Check out our latest blog post! We're excited about this important validation early cancer detection via circulating tum...
02/11/2014

Check out our latest blog post! We're excited about this important validation early cancer detection via circulating tumor cells! http://www.isetbyrarecells.com/detection-cancer-circulating-tumor-cells-leads-rapid-early-stage-treatment-without-recurrence/

Earlier this year, the New York Times published an article on research into the detection of asymptomatic or “silent” cancers by finding circulating tumor cells (CTCs), a method sometimes referred to as “liquid biopsy.” In that article, noted NYT science reporter Andrew Pollack wrote: “For all the p…

http://www.isetbyrarecells.com/sentinel-cells-the-early-clues-to-silent-tumors/
30/10/2014

http://www.isetbyrarecells.com/sentinel-cells-the-early-clues-to-silent-tumors/

How exactly do tumors migrate to other parts of the body? This animation shows the journey these deadly cells travel to sow new tumors in parts of the body distant from where the original tumor took root. We call these “Sentinel Tumor Cells.” This process starts with Primary Tumor Angiogenesis. Angi…

Adresse

101 Rue De Sèvres
Paris
75006

Téléphone

01.72.60.64.66

Site Web

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Rarecells Diagnostics publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Raccourcis

Partager

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram